血必净联合抗菌药物治疗ICU重症肺炎的临床效果分析

Analysis on the Clinical Effect of Xuebijing Combined with Antibiotics in the Treatment of ICU Severe Pneumonia

目的探讨血必净联合抗菌药物治疗ICU重症肺炎(SP)的临床效果。方法60例ICU SP患者随机分为两组各30例,抗菌组给予抗菌药物治疗,联合组给予血必净联合抗菌药物治疗,比较两组的临床疗效及不良反应。结果治疗后,联合组的PCT、CRP水平及CPIS评分均显著低于抗菌组,总有效率显著高于抗菌组(P<0.05)。两组的不良反应发生率比较,差异无统计学意义(P>0.05)。结论血必净联合抗菌药物治疗ICU重症肺炎的效果显著,可有效控制患者全身感染状态,安全性高。

Objective To explore the clinical effect of Xuebijing combined with antibiotics in the treatment of ICU severe pneumonia(SP).Methods 60 ICU patients with SP were randomly divided into two groups,with 30 cases in each group.The antibacterial group was treated with antibiotics,and the combined group was treated with Xuebijing combined with antibiotics.The clinical efficacy and adverse reactions were compared between the two groups.Results After treatment,the levels of PCT and CRP,and CPIS score in the combined group were significantly lower than those in the antibacterial group,and the total effective rate was significantly higher than that in the antibacterial group(P<0.05).No statistical difference was found between the two groups in the incidence of adverse reactions(P>0.05).Conclusions Xuebijing combined with antibiotics in the treatment of ICU severe pneumonia has significant effect and high safety,and can effectively control the body infection status of patients.